Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection
- 11 September 2006
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (14) , 1795-1804
- https://doi.org/10.1097/01.aids.0000244198.65263.17
Abstract
Objective: We have recently found that during HIV-1 infection, CD4 T cells overexpress a ligand of the NK activating receptor NKp44 (NKp44L) and are sensitized to NK lysis. Expression of NKp44L is triggered by a motif (3S) from the gp41, highly conserved in all HIV-1 clades. The objectives were to determine whether anti-3S antibodies were produced, could counteract 3S-CD4 interactions and were correlated to CD4 cell count and NKp44L expression in HIV-infected patients. Design: Anti-3S antibodie production was studied in HIV-infected patients at various stages of the disease, including a longitudinal study in Asymptomatiques à Long Terme (ALT) patients. Methods: Specimens from 193 HIV-1 infected patients were examined. Anti-3S antibodies were detected by ELISA, and NKp44L expression was analysed by flow cytometry. NK cytotoxicity against CD4NKp44L cells was determined in the presence of anti-3S antibodies. Results: Anti-3S antibodies were detected in 28.5% of HIV-infected patients. They were positively correlated to CD4 cell counts (P = 0.01) and inversely correlated to NKp44L expression (P = 0.007). Particularly, in ALT patients, a longitudinal study revealed that the CD4 cell count slope differed according to the presence or absence of anti-3S antibodies (−0.98 cells/month versus −7.48 cells/month, P > 0.001). In addition, a clear inhibition of CD4NKp44L NK lysis was observed in relationship to anti-3S antibodies titres. Conclusions: These results strongly suggested that anti-3S antibodies might affect disease course in inhibiting NKp44L expression and CD4 sensitivity to NK lysis. In linking specific adaptive immunity to the innate immunity induced by the 3S motif, this study may have important implications for therapeutic vaccines against AIDS.Keywords
This publication has 41 references indexed in Scilit:
- NK cytotoxicity against CD4+T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligandProceedings of the National Academy of Sciences, 2005
- Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41Immunity, 2005
- The Caveolin-1 Binding Domain of HIV-1 Glycoprotein gp41 Is an Efficient B Cell Epitope Vaccine Candidate against Virus InfectionImmunity, 2004
- HIV vaccine design and the neutralizing antibody problemNature Immunology, 2004
- Identifying epitopes of HIV-1 that induce protective antibodiesNature Reviews Immunology, 2004
- Defining the protective antibody response for HIV-1.Current Molecular Medicine, 2003
- Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humansAIDS, 2002
- CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?Nature Medicine, 2002
- The dynamics of CD4+ T-cell depletion in HIV diseaseNature, 2001
- The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and ImmunogensScience, 1998